Browse studies

Find your next paid study

26,835 recruiting studies available now

Phase I Study Of PLM-102 In Patients With Relapsed And Refractory Acute Myeloid Leukemia

The goal of this clinical research study is to find the highest tolerable dose of PLM-102 that can be given to patients who have AML/MDS that is refractory and…

Acute Myeloid Leukemia

Estimated

~$10 – $6,250

M.D. Anderson Cancer CenterNCT07549464

Studies of the Natural History of Sickle Cell Disease

This study is not a treatment protocol and no experimental treatments are involved. Study participants may be seen as needed for clinical, translational and ba…

Pain Crisis

Estimated

~$10 – $675

National Heart, Lung, and Blood Institute (NHLBI)NCT00081523

Phase 3

A Phase 3, Randomized, Open-Label Study of Linvoseltamab Versus Daratumumab in Participants With Smoldering Multiple Myeloma at High Risk of Developing Multiple Myeloma

This study is researching an experimental drug called linvoseltamab (also called "study drug") compared to another drug called daratumumab, in participants wit…

High Risk Smoldering Multiple Myeloma (HR-SMM)

Estimated

~$10 – $8,750

Regeneron PharmaceuticalsNCT07393282

Phase 3

A Randomized, Open-label, Multicentric, Two-arm Pivotal Trial of SonoCloud-9 Combined With Carboplatin (CBDCA) vs Standard of Care Lomustine (CCNU) or Temozolomide (TMZ) in Patients Undergoing Planned Resection for First Recurrence Glioblastoma.

The brain is protected from any toxic or inflammatory molecule by the blood-brain barrier (BBB). This physical barrier is located at the level of the blood ves…

GlioblastomaRecurrent GlioblastomaGBM

A Double-blind, Double-dummy, Parallel Group, Multicenter Phase 3 Extension Study Evaluating the Long-term Safety and Efficacy of 2 Doses of Remibrutinib in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

The purpose of this study is to evaluate the long-term safety, tolerability and efficacy of remibrutinib (LOU064) in adult participants with moderate to severe…

Hidradenitis Suppurativa

Estimated

~$10 – $8,750

Novartis PharmaceuticalsNCT07665437

Phase 2

A Double-Blind, Randomized, Placebo-Controlled Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation During Acute HIV Infection to Induce HIV Remission

A5388 is a phase II, two-arm, randomized, double-blind, placebo-controlled study that will enroll 48 antiretroviral therapy (ART)-naïve adults with acute HIV i…

Acute HIV Infection

Estimated

~$10 – $5,625

National Institute of Allergy and Infectious Diseases (NIAID)NCT05719441

Observational

Sensorimotor Basis of Speech Motor Learning and Retention

The overall goal of this research is to test a new model of speech motor learning, whose central hypothesis is that learning and retention are associated with …

Speech

Estimated

~$10 – $6,250

Yale UniversityNCT06467292

Phase 3

A Phase 3, Two-part, Randomized, Open-label, Adaptive Study Comparing BMS-986365 Versus Investigator's Choice of Therapy Comprising Either Docetaxel or Second Androgen Receptor Pathway Inhibitor (ARPI), in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) - rechARge

The purpose of this study is to compare the efficacy and safety of BMS-986365 versus the investigator's choice of therapy in participants with Metastatic Castr…

Metastatic Castration-resistant Prostate Cancer

Evaluation of a Novel Optical Microscope With a Deep Depth of Field (DeepDOF) to Provide Histologic-quality Images on Cervical Biopsies and Loop Electrosurgical Excision Procedure (LEEP) Specimens at the Point-of-care

All patients will be enrolled in Mozambique and Brazil. They will provide informed consent to use their cervical biopsy and/or LEEP specimens for imaging with …

Cervical CancerHIV

Estimated

~$10 – $6,250

M.D. Anderson Cancer CenterNCT06850402

Phase 1

A Phase 1/2 Study of BMS-986525 as Monotherapy and in Combination Therapy in Participants With Relapsed/Refractory Small Cell Lung Cancer

The purpose of this study is to assess the safety and tolerability of BMS-986525 alone and in combination with Pumitamig in participants with Relapsed/Refracto…

Relapsed/Refractory Small Cell Lung Cancer

Estimated

~$10 – $7,500

Bristol-Myers SquibbNCT07325136

Observational

Innovative Cognitive-Motor Training for Prevention of AD/ADRD

Alzheimer's disease and related dementias (AD/ADRD) greatly affect memory and daily activities in older adults. Mild Cognitive Impairment (MCI) is an early sta…

MCIAging

Estimated

~$10 – $6,250

University of Illinois at ChicagoNCT07160582

Phase 2

Phase 2 Trial of Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-Hodgkin Lymphomas

Background: The drug Nivolumab has been approved to treat some cancers. Researchers want to see if it can slow the growth of other cancers. They want to study…

Epstein-Barr Virus InfectionsLymphomaLymphoproliferative Disorder+1 more

Estimated

~$10 – $5,625

National Cancer Institute (NCI)NCT03258567